Sign in
Stories
Health Innovations: Diagnostics & Profiling
Share
Advancements in Cancer Treatment and Mar...
Advancements in Prostate Cancer Diagnost...
Oncology Innovations Showcase at AACR
Acrivon Therapeutics' Precision Medicine...
BMS Showcases Diverse Approaches in Mult...
BMS Showcases Myeloma Pipeline and Abecm...
Overview
API
The global monkeypox diagnostics market is expanding due to the outbreak reaching non-African regions. Companies are developing tests to address this issue. Immunis.AI released a study in The Journal of Urology showing its blood-based platform can stratify prostate cancer risk.
Ask a question
How might the global spread of monkeypox impact healthcare systems and diagnostic markets worldwide?
In what ways could advancements in blood-based immune profiling reshape personalized medicine approaches?
What are the implications of Immunis.AI's study on the future of prostate cancer diagnosis and treatment?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Dec 2023
Jan 2024
Feb 2024
Mar 2024
Coverage